[Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
D000328:Adult; D006332:Cardiomegaly / Q000473:pathology*; D002752:Chlorthalidone / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D005080:Exercise Test; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010096:Oxprenolol / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D010096:Oxprenolol; D002752:Chlorthalidone
Riduzione dell'ipertrofia ventricolare sinistra e aumentata tolleranza allo sforzo in pazienti ipertesi dopo terapia antipertensiva mediante oxprenololo retard e clortalidone.